Annexon, Inc. - stock earnings
ANNX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -32.5 million USD | ? USD |
2023Q2 | -35.2 million USD | ? USD |
2023Q1 | -35.6 million USD | ? USD |
2022Q4 | -32.1 million USD | ? USD |
2022Q3 | -34.0 million USD | ? USD |
2022Q2 | -36.9 million USD | ? USD |
2022Q1 | -35.3 million USD | ? USD |
2021Q4 | -37.4 million USD | ? USD |
2021Q3 | -35.6 million USD | ? USD |
2021Q2 | -31.3 million USD | ? USD |
2021Q1 | -26.0 million USD | ? USD |
2020Q4 | -23.2 million USD | ? USD |
2020Q3 | -15.6 million USD | ? USD |
2020Q2 | -12.2 million USD | ? USD |
2020Q1 | -12.3 million USD | ? USD |
2019Q4 | -8.9 million USD | ? USD |
2019Q3 | -10.2 million USD | ? USD |
2019Q2 | -9.4 million USD | ? USD |
2019Q1 | -8.7 million USD | ? USD |
ANNX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -140.7 million USD | ? USD |
2022 | -138.3 million USD | ? USD |
2021 | -127.8 million USD | ? USD |
2020 | -62.7 million USD | ? USD |
2019 | -37.2 million USD | ? USD |
2018 | -18.3 million USD | ? USD |
2017 | -18.7 million USD | ? USD |
ANNX
Price: $4.70
52 week price:
Earnings Per Share: -1.77 USD
P/E Ratio: -2.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 124730
Market Capitalization: 505.0 million